Combo Treatment Scores Big in BCG-Unresponsive Bladder Cancer - Medpage Today
5/15/2022 12:00:00 AM2 years 11 months ago
by Mike Bassett
by Mike Bassett
Significantly durable response with VesAnktiva-Bacillus Calmette-Guérin duo
NEW ORLEANS -- Add-On IL15RaFc superagonist N-803 (VesAnktiva) to Bacillus Calmette-Guérin (BCG) treatment led to "a clinically meaningful benefit" in BCG-unresponsive non-muscle invasive bladder can… [+4198 chars]
full article...